Explore insights and strategies for managing MG long-term.
-
-
Researchers uncover new pathway driving myasthenia gravis progression
-
New tool developed to help identify patients at risk of myasthenic crisis
-
Argenx announces positive results from study of efgartigimod for seronegative MG
-
Study finds efgartigimod helps cut steroid use while boosting daily function in MG
-
AI study reveals hidden struggles among people with myasthenia gravis
-
Rituximab shows promise for treating rare form of MG